Artiva Biotherapeutics, Inc. Common Stock (ARTV)
Filed: 7 Mar 22, 4:28pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 7, 2022, with respect to the financial statements of Artiva Biotherapeutics, Inc., included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
March 7, 2022